Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation

Kalliopi Tsakiri; Vassiliki Kotoula; Sotirios Lakis; Judith Müller; Florentia Fostira; Mattheos Bobos; Prodromos Hytiroglou; George Fountzilas

doi:10.1200/PO.17.00015

Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation

Kalliopi Tsakiri, Vassiliki Kotoula, Sotirios Lakis, Judith Müller, Florentia Fostira, Mattheos Bobos, Prodromos Hytiroglou, George Fountzilas

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	JCO Precision Oncology
Volume	2017
Issue number	1
DOIs	https://doi.org/10.1200/PO.17.00015
State	Published - 2017
Externally published	Yes

Access to Document

10.1200/PO.17.00015

Cite this

@article{1c0b24727ad14e82826841b1a635a085,

title = "Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation",

author = "Kalliopi Tsakiri and Vassiliki Kotoula and Sotirios Lakis and Judith M{\"u}ller and Florentia Fostira and Mattheos Bobos and Prodromos Hytiroglou and George Fountzilas",

year = "2017",

doi = "10.1200/PO.17.00015",

language = "English",

volume = "2017",

pages = "1--7",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation

AU - Tsakiri, Kalliopi

AU - Kotoula, Vassiliki

AU - Lakis, Sotirios

AU - Müller, Judith

AU - Fostira, Florentia

AU - Bobos, Mattheos

AU - Hytiroglou, Prodromos

AU - Fountzilas, George

PY - 2017

Y1 - 2017

UR - https://www.scopus.com/pages/publications/85074780571

U2 - 10.1200/PO.17.00015

DO - 10.1200/PO.17.00015

M3 - Article

AN - SCOPUS:85074780571

SN - 2473-4284

VL - 2017

SP - 1

EP - 7

JO - JCO Precision Oncology

JF - JCO Precision Oncology

IS - 1

ER -